Abbott Laboratories (ABT)
116.67
+0.03
(+0.03%)
USD |
NYSE |
Aug 24, 16:00
116.62
-0.05
(-0.04%)
After-Hours: 20:00
Abbott Laboratories Shareholders Equity (Quarterly) : 51.11B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.11B |
| March 31, 2026 | 52.06B |
| December 31, 2025 | 52.13B |
| September 30, 2025 | 50.95B |
| June 30, 2025 | 50.56B |
| March 31, 2025 | 48.81B |
| December 31, 2024 | 47.66B |
| September 30, 2024 | 39.80B |
| June 30, 2024 | 39.32B |
| March 31, 2024 | 38.81B |
| December 31, 2023 | 38.60B |
| September 30, 2023 | 37.48B |
| June 30, 2023 | 37.17B |
| March 31, 2023 | 37.01B |
| December 31, 2022 | 36.69B |
| September 30, 2022 | 35.68B |
| June 30, 2022 | 36.49B |
| March 31, 2022 | 35.40B |
| December 31, 2021 | 35.80B |
| September 30, 2021 | 34.42B |
| June 30, 2021 | 33.80B |
| March 31, 2021 | 33.56B |
| December 31, 2020 | 32.78B |
| September 30, 2020 | 31.39B |
| June 30, 2020 | 30.58B |
| Date | Value |
|---|---|
| March 31, 2020 | 30.22B |
| December 31, 2019 | 31.09B |
| September 30, 2019 | 31.82B |
| June 30, 2019 | 31.69B |
| March 31, 2019 | 30.92B |
| December 31, 2018 | 30.52B |
| September 30, 2018 | 30.70B |
| June 30, 2018 | 30.58B |
| March 31, 2018 | 31.40B |
| December 31, 2017 | 30.90B |
| September 30, 2017 | 32.03B |
| June 30, 2017 | 31.60B |
| March 31, 2017 | 31.36B |
| December 31, 2016 | 20.54B |
| September 30, 2016 | 20.78B |
| June 30, 2016 | 20.68B |
| March 31, 2016 | 20.72B |
| December 31, 2015 | 21.21B |
| September 30, 2015 | 21.11B |
| June 30, 2015 | 23.01B |
| March 31, 2015 | 21.87B |
| December 31, 2014 | 21.53B |
| September 30, 2014 | 22.89B |
| June 30, 2014 | 23.60B |
| March 31, 2014 | 23.39B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 24.42B |
| Boston Scientific Corp. | 24.93B |
| DexCom, Inc. | 2.621B |
| Insulet Corp. | 1.422B |
| Intuitive Surgical, Inc. | 18.17B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.22B |
| Total Liabilities (Quarterly) | 57.45B |
| Debt to Equity Ratio | 0.638 |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | -2.47% |